|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From Airways Disease Section, National Heart and Lung Institute, Imperial College, London, UK
p.j.barnes{at}imperial.ac.uk
Abstract
BackgroundThe role of neutrophils in exacerbations of asthma is poorly understood. We examined the effect of withdrawal of inhaled corticosteroids on sputum inflammatory indices in a double-blind study in patients with moderate stable asthma.
MethodsFollowing a 2-week run in period, 24 subjects were randomized to receive either budesonide (400 µg twice a day) or placebo and the study was continued for a further 10 weeks. Results: 8/12 patients developed loss of asthma control over the 10 week period of steroid withdrawal, whereas only 1/10 with budesonide treatment exacerbated. Those with an exacerbation had increased sputum IL-8 (p<0.0001) and increased sputum neutrophil numbers (p<0.0001) compared to those without an exacerbation. The significant elevation in sputum interleukin-8 (IL-8) and neutrophil counts initially occurred 2 weeks prior to an exacerbation. Sputum neutrophilia correlated positively with changes in IL-8 levels (r2 = 0.76, p=0.01).
ConclusionsRapid withdrawal of inhaled corticosteroids results in an exacerbation of asthma that is preceded by an increase in sputum neutrophils and IL-8 concentrations, in contrast to an increase in eosinophils reported in previous studies where inhaled steroids are slowly tapered.
Key Words: asthma interleukin-8 neutrophil exacerbation
Read all eLetters
eLetters:
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |